ADB-FUBHQUCA

From WikiMD's Wellness Encyclopedia

Revision as of 21:12, 11 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Synthetic cannabinoid


ADB-FUBHQUCA
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


ADB-FUBHQUCA is a synthetic cannabinoid that has been used in scientific research and is a designer drug. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system.

Chemical structure

ADB-FUBHQUCA belongs to the indazole-3-carboxamide family of synthetic cannabinoids. Its chemical structure includes a 1-(4-fluorobenzyl) group attached to an indazole core, with an amide linkage to a tert-leucine moiety. The presence of the fluorobenzyl group is a common feature in many synthetic cannabinoids, contributing to their high affinity for cannabinoid receptors.

Pharmacology

As a synthetic cannabinoid, ADB-FUBHQUCA acts as a full agonist at the CB1 and CB2 receptors. These receptors are part of the G protein-coupled receptor family and are primarily involved in the modulation of neurotransmitter release in the central nervous system. The activation of these receptors by ADB-FUBHQUCA can lead to effects similar to those of tetrahydrocannabinol (THC), the active component of cannabis.

Legal status

The legal status of ADB-FUBHQUCA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. It is often included in legislation targeting synthetic cannabinoids and other designer drugs.

Health effects

The use of ADB-FUBHQUCA, like other synthetic cannabinoids, can lead to a range of adverse health effects. These may include tachycardia, hypertension, nausea, vomiting, anxiety, and hallucinations. In severe cases, it can lead to seizures, psychosis, and renal failure.

Synthesis

The synthesis of ADB-FUBHQUCA involves the reaction of 1-(4-fluorobenzyl)-1H-indazole-3-carboxylic acid with tert-leucine and subsequent conversion to the amide. This process requires careful control of reaction conditions to ensure the purity and yield of the final product.

Related pages

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD weight loss doctors team
W8MD weight loss doctors team

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

NYC weight loss doctor appointmentsNYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Linkedin_Shiny_Icon Facebook_Shiny_Icon YouTube_icon_(2011-2013) Google plus


Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.